GeneFerm Biotechnology (1796) reported revenue of NT$58.5 million for Oct 2026, +0.1% year on year and +21.5% from the previous month. Revenue for Jan–Oct 2026 was NT$550.8 million (-1.3% year on year).
In Oct 2026, it ranked No. 30 by revenue among 34 Food companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$58.5 million | +0.1% | +21.5% |
| Sep 2026 | NT$48.2 million | -12.4% | -16.0% |
| Aug 2026 | NT$57.3 million | -10.9% | -11.3% |
| Jul 2026 | NT$64.6 million | +39.8% | -8.4% |
| Jun 2026 | NT$70.6 million | +22.8% | +50.5% |
| May 2026 | NT$46.9 million | -8.9% | -8.8% |
| Apr 2026 | NT$51.4 million | -12.6% | -2.5% |
| Mar 2026 | NT$52.8 million | -12.9% | +14.6% |
| Feb 2026 | NT$46 million | +2.7% | -15.4% |
| Jan 2026 | NT$54.4 million | -10.8% | -12.1% |
| Dec 2025 | NT$61.9 million | +11.6% | +8.8% |
| Nov 2025 | NT$56.9 million | +19.7% | -2.7% |
| Oct 2025 | NT$58.5 million | +12.4% | +6.3% |
| Sep 2025 | NT$55 million | +6.4% | -14.5% |
| Aug 2025 | NT$64.3 million | +56.6% | +39.2% |
| Jul 2025 | NT$46.2 million | +18.2% | -19.6% |
| Jun 2025 | NT$57.5 million | +66.5% | +11.7% |
| May 2025 | NT$51.5 million | +55.3% | -12.5% |
| Apr 2025 | NT$58.9 million | +22.1% | -2.8% |
| Mar 2025 | NT$60.6 million | +76.3% | +35.2% |
| Feb 2025 | NT$44.8 million | +35.6% | -26.5% |
| Jan 2025 | NT$61 million | +19.7% | +10.1% |
| Dec 2024 | NT$55.4 million | -5.8% | +16.6% |
| Nov 2024 | NT$47.5 million | -24.0% | -8.6% |
| Oct 2024 | NT$52 million | -15.4% | +0.7% |
Jan–Oct 2026 cumulative: NT$550.8 million (-1.3% YoY)
Other Food companies
Compare with peers: GeneFerm Biotechnology vs UNI-PRESIDENT / GeneFerm Biotechnology vs GREATWALL / GeneFerm Biotechnology vs CPE
| Company | Revenue | YoY |
|---|---|---|
| UNI-PRESIDENT | NT$57.1 billion | +5.3% |
| GREATWALL | NT$9.66 billion | +14.6% |
| CPE | NT$2.66 billion | +13.4% |
| TTET | NT$2.48 billion | +33.4% |
| SFC | NT$2.08 billion | -3.5% |
| WEI CHUAN | NT$1.88 billion | +4.4% |
| NAMCHOW | NT$1.87 billion | +3.1% |
| LHIHC | NT$1.1 billion | +8.0% |
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16